A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of a Single Infusion of Bezlotoxumab (MK-6072, Human Monoclonal Antibody to C. difficile Toxin B) in Children Aged 1 to
Clinical Trial Grant
Administered By
Pediatrics, Infectious Diseases
Awarded By
Merck Sharp & Dohme
Start Date
July 3, 2018
End Date
July 31, 2022
Administered By
Pediatrics, Infectious Diseases
Awarded By
Merck Sharp & Dohme
Start Date
July 3, 2018
End Date
July 31, 2022